Progress in Biosimilar Market Highlights Week in Specialty Pharmacy

Article

Top news of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/progress-in-biosimilar-market-highlights-week-in-s" target="_blank">View the story "Progress in Biosimilar Market Highlights Week in Specialty Pharmacy" on Storify</a>]

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Related Content
Image Credit: © eddows - stock.adobe.com

Persistent Epigenetic Changes in Immune Cells Following Hepatitis C Recovery

Alexandra Gerlach, Associate Editor
July 26th 2024
Article
Pharmacy Focus: World Psychedelics Day

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
June 14th 2024
Podcast
Amyloid plaques forming between neurons

JNJ-2056, Targeting Tau Protein, Receives FDA Fast Track Designation for Alzheimer Disease

Luke Halpern, Assistant Editor
July 26th 2024
Article
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

January 25th 2024
Podcast
Biosimilar, Humira | Image Credit: lexiconimages - stock.adobe.com

Patient Affordability Program for Adalimumab Biosimilar Is Launched at GoodRx

Ashley Gallagher, Associate Editor
July 25th 2024
Article
The HIV-AIDS virus visualized.

Twice-Yearly Lenacapavir Effective in Significantly Reducing HIV Infections in Cisgender Women

Luke Halpern, Assistant Editor
July 25th 2024
Article